Data on the number of cases for these diseases from the pre-vaccine era is hard to come by, and even the case counts are ...
A vaccine against norovirus, the dreaded “winter vomiting bug”, could be closer than you think: early clinical trials have ...
US-based PharmaJet, a company dedicated to enhancing injectable performance through needle-free injection technology, has ...
On an August morning in 1949, when I was six, I got out of bed and collapsed on the floor. By evening, I was paralyzed from the neck down and in an iron lung. I spent the next five months in a polio ...
In Jere Local Government Area (LGA) of Borno State, four-year-old Amina* from Mairi Ward in Buladina settlement has received ...
Science Africa on MSN12h
Vaccination: Kenya Urged to Fulfil GAVI Co-financing ObligationBy Sharon AtienoKenya risks a vaccination crisis if the country does not honour its Global Alliance for Vaccines and ...
Perry County voters will decide Tuesday, April 8, who will fill three open seats on the Health Department Board. Four ...
Topline data were announced from a phase 2/3 trial evaluating Flebogamma 5% DIF (immune globulin intravenous ) in patients with post-polio syndrome (PPS).
Grifols has shared positive results from its clinical trial evaluating the efficacy and safety of intravenous immunoglobulin to treat patients with PPS.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback